Here are today's things: AMZN (BUY) $202.815 (SALE) $209.42 GOOGL (BUY) $296.39 (SALE) $304.71 META (BUY) $587.70 (SALE) $606.43 MSFT (BUY) $379.72 (SALE) $386.85 FINANCIALS APO (SALE) $114.02 AXP (BUY) $292.60 (SALE) $305.51 BAC (BUY) $46.79 (SALE) $48.07 ...
Read in context ›Trulieve Cannabis Stock (TCNNF)
Track Trulieve Cannabis stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
TCNNF
Trulieve Cannabis
healthcare
$11.69
▲ +5.98 (+149.13%) past year
Market Cap
$1.65B
P/E Ratio
—
1Y Return
+149.13%
EPS (TTM)
-$0.42
Read the latest TheStreet Pro articles mentioning Trulieve Cannabis, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
5 articlesDaily Diary Mentions
43 mentionsThings I Did Today Things I Did Today Here are today's things: * Back long the indexes: SPY $657.51 QQQ $590.27 * Added to DIS $99.23. * Added to NKE at $52.96 * Added to BAC $46.39, C $107.33. * Added to MSOS $3.75 and TCNNF $6.16. * Added to PG $146.03
Read in context ›Multi-State Cannabis Operators Have Successfully Overcome a Potential 'Refinancing Cliff' The largest financial hurdle (that I previously feared) facing the cannabis industry has been successfully leapt over by most of the multi-state operators. Over the last several months Verrano, Green Thumb, Trulieve, TerrAscend, Curaleaf and others have refinanced their debt with credit facilities ...
Read in context ›Getting Ready for Cannabis Rescheduling Some individual cannabis buys this afternoon: * GLASF $7.43 * ( GTBIF ) $6.42 * ( TCNNF ) $6.15
Read in context ›Say No To Drugs (And Investing in Cannabis Equities) * President Trump's endorsement of rescheduling was not forceful and failed to resolve a number of important issues * Trade cannabis equities, don't invest in cannabis stocks "I have always told me kids, 'don't take drug…
Read in context ›